News | Magnetic Resonance Imaging (MRI) | June 07, 2019

Amsterdam University Medical Center Wins MR Solutions' Image of the Year Award

Competition had leading academics evaluate MRI, PET, CT and combination images from MR Solutions users around the world

A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

A high-quality MR abdominal image of a pregnant Sprague Dawley rat

Figure 2. A high-quality MR abdominal image of a pregnant Sprague Dawley rat showing multiple embryonic implants, from Sydney Imaging Core Research Facility.

A PET-MR whole body image of an eight-week-old BALB/c mouse showing a CT26 xenograft tumor

Figure 3. A PET-MR whole body image of an eight-week-old BALB/c mouse showing a CT26 xenograft tumor from Centre Georges François Leclerc centre in France.

June 7, 2019 — The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular research image. Preclinical image submissions came in from most of MR Solutions’ users across the world. The winners, which were presented at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, May 11-16 in Montreal, QC, Canada, were chosen by a panel of leading academics who examined images from magnetic resonance imaging (MRI), positron emission tomography (PET) or computed tomography (CT) – or a combination of imaging modalities.

The winning submission was carried out by Amsterdam Ph.D. researcher Gustav Strijkers. This technique was used in cardiac research to produce a high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse (figure 1). The exceptional quality and accuracy of the cardiomyopathy research significantly advances the preclinical imaging sector in the battle to better understand heart muscle disease and treatment.

The submission from Sydney Imaging Core Research Facility came a close second place for the high-quality MR abdominal image of a pregnant Sprague Dawley rat (figure 2). The resulting image showed multiple embryonic implants and was ranked for image clarity, research interpretation and understanding.

The third place submission by the Centre Georges François Leclerc centre in France was a PET-MR whole body image of an eight-week-old BALB/c mouse showing a CT26 xenograft tumor (figure 3). This displayed a clear breakdown of the metabolic, hypoxic and necrotic regions of the tumor. Additional axial images showed further localized information on the high and low uptake areas of 18F-FMISO using a 2T signal.

For more information: www.mrsolutions.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Achenbach to Receive Inaugural 2019 Stephan Achenbach Pioneer Award in Cardiovascular CT
News | Cardiac Imaging | July 10, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present Stephan Achenbach, M.D., FSCCT with the inaugural...
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...
Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology
News | Cardiac Imaging | July 08, 2019
Jonathon A. Leipsic, M.D., FSCCT, is the recipient of the 2019 DeHaan Award for Innovation in Cardiology, announced by...